• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[白细胞介素-8表达与乳腺癌预后的关系]

[The relationship between expression of interleukin-8 and prognosis of breast cancer].

作者信息

Yao Chen, Wang Shen-ming, Xie Dan, Wu Hui-xi, Chen Dong-ying, Lin Ying

机构信息

Center of Breast Disease, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):900-3.

PMID:17067482
Abstract

OBJECTIVE

To investigate the expression of interleukin-8 (IL-8) and its prognostic significance in breast cancer.

METHODS

Expression of IL-8 in 113 breast cancers, 19 breast benign tumors and 20 breast normal tissues was examined by tissue microarray using immunohistochemistry, and the association of IL-8 expression with patient's clinico-pathological characteristics and prognosis was further analyzed.

RESULTS

The positive rate of IL-8 expression in breast cancer was 27.4%, which was significantly higher than that in benign tumor and normal tissue of breast (P = 0.002). IL-8 expression related to histological type (P = 0.040) and lymph node status (P = 0.021). The expression of IL-8 was observed to correlate negatively with ER and PR status (P = 0.015 and P = 0.034), and correlate positively with C-erbB-2 status (P = 0.002). In addition, Kaplan-Meier curves of disease-free survival analysis showed a significant difference between IL-8 positive groups and negative group (P = 0.031).

CONCLUSIONS

IL-8 might be a poor prognostic factor for human breast cancer, and also might be a novel molecular marker to predicate the occurrence and progression of breast cancer.

摘要

目的

探讨白细胞介素-8(IL-8)在乳腺癌中的表达及其预后意义。

方法

采用组织芯片免疫组化法检测113例乳腺癌、19例乳腺良性肿瘤及20例乳腺正常组织中IL-8的表达,并进一步分析IL-8表达与患者临床病理特征及预后的关系。

结果:乳腺癌中IL-8表达阳性率为27.4%,显著高于乳腺良性肿瘤及正常组织(P = 0.002)。IL-8表达与组织学类型(P = 0.040)及淋巴结状态(P = 0.021)有关。观察到IL-8表达与ER和PR状态呈负相关(P = 0.015和P = 0.034),与C-erbB-2状态呈正相关(P = 0.002)。此外,无病生存分析的Kaplan-Meier曲线显示IL-8阳性组与阴性组之间存在显著差异(P = 0.031)。

结论

IL-8可能是人类乳腺癌的不良预后因素,也可能是预测乳腺癌发生和进展的新型分子标志物。

相似文献

1
[The relationship between expression of interleukin-8 and prognosis of breast cancer].[白细胞介素-8表达与乳腺癌预后的关系]
Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):900-3.
2
[The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer].巨噬细胞移动抑制因子表达与乳腺癌预后的关系
Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):520-3.
3
[Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].[癌基因C-erbB2表达与乳腺癌中雌激素受体、孕激素受体及PS2的关系及其预后意义]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):334-6, 357.
4
[Association of CK20 expression with the progression, metastasis and prognosis of breast cancer].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Aug;25(8):706-7.
5
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.乳腺癌中FOXA1的表达——与腔面A型及生存的相关性
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122.
6
[Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].[乳腺癌患者中Her-2过表达与内分泌状态及他莫昔芬治疗反应的相关性]
Zhonghua Yi Xue Za Zhi. 2007 Dec 11;87(46):3268-71.
7
[Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].[乳腺癌组织中c-erbB2癌蛋白表达的免疫组化研究]
Zhonghua Zhong Liu Za Zhi. 1997 Jul;19(4):287-9.
8
Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.人表皮生长因子受体2阴性乳腺癌标本中趋化因子受体CXCR4水平升高预示复发。
J Surg Res. 2007 Jul;141(1):53-9. doi: 10.1016/j.jss.2007.03.015.
9
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.人表皮生长因子受体2状态与雌激素受体(ER)阴性患者的淋巴结受累相关,但与适合细胞毒性化疗的ER阳性早期乳腺癌患者的分级相关。
J Clin Oncol. 2007 Oct 1;25(28):4423-30. doi: 10.1200/JCO.2007.11.0973.
10
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.荧光原位杂交技术在确定乳腺癌HER2基因扩增中的预后效用
Oncol Rep. 2008 Mar;19(3):651-6.